Embracing new innovation in the face of Brexit

06:46 EDT 13 Jul 2018 | Manufacturing Chemist

Dr Paul Catchpole commented at the NICE Annual Conference that adopting innovations will help bring investment into the UK and crucially help get more NHS patients onto ground breaking clinical trials programmes

Original Article: Embracing new innovation in the face of Brexit


More From BioPortfolio on "Embracing new innovation in the face of Brexit"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...